-
Mark Cuban's online pharmacy collaborates with Zócalo Health
Mark Cuban Cost Plus Drug Co. will collaborate with Zócalo Health, a healthcare company that focuses on Latino patients, according to a news release shared with Becker's. -
Akorn: From financial troubles to a shutdown and intensifying drug shortages
It has been about a month since a U.S. drugmaker closed all operations, and since then, at least 14 drugs have gone into shortage and four are discontinued. -
Ozempic's No. 1 competitor could upend its success
While droves of patients experiencing obesity have turned to Novo Nordisk's Ozempic for treatment, the drug Mounjaro from its competitor Eli Lilly is closely trailing its success, according to an April 3 report from The Wall Street Journal. -
UCHealth aims to remove language barriers in prescription medications
Medication literacy and patient-centered labels have been linked to improved health outcomes. Now, Denver-based UCHealth has announced plans to take this a step further by implementing a program to translate prescription instructions into 26 languages. -
New York launches Medicaid pharmacy benefit program
New York state aims to increase access to affordable prescription medications through its new pharmacy benefit program, which launched April 1. -
5 weeks later, Akorn's closure racks up 14 swelling drug shortages
Some drug shortages have worsened because of the closure of Gurnee, Ill.-based Akorn Operating Co., according to the American Society of Health-System Pharmacists. -
Pharmacy workers are more burnt out
As the healthcare workforce struggles with burnout, pharmacy staffs aren't immune to the growing flame of chronic workplace stress. -
15 best pharmacy schools for first-time NAPLEX pass rates
About 120 students who took the North American Pharmacist Licensure Examination test at one California school in 2022 passed their first time, according to the National Association of Boards of Pharmacy. -
Canadian province slows Ozempic sales to US: 4 updates
Eleven days after the domestic Ozempic shortage partially ended, an official in British Columbia said March 28 the province is limiting how much of the Type 2 diabetes drug its online pharmacies can sell to U.S. and other non-Canadian residents. -
How an alleged monkey smuggling scheme can stifle drug research
The National Association for Biomedical Research and other medical groups are urging federal officials to help amid a shortage of monkeys they say is disrupting research for lifesaving medications. -
Arizona nixes physician prescription requirement for birth control
Arizona passed a bill which allows pharmacists to dispense birth control with non-patient specific orders, the Observer Today reported March 30. -
FDA panel sets date for OTC birth control meeting
On May 9 and May 10, an FDA advisory panel will discuss whether to recommend the agency approve what could be the first over-the-counter birth control pill. -
J&J abandons RSV vaccine plans
Johnson & Johnson is stopping work to develop a respiratory syncytial virus vaccine for older adults — a move that will allow the company to "prioritize the most transformational assets for ongoing investment." -
'It's monumental': FDA approves 1st OTC naloxone nasal spray
The FDA approved the first over-the-counter Narcan (naloxone) product on March 29. -
Rural hospitals could soon have a harder time stocking drugs
As more drugs slip into shortage, rural hospitals could lose their failsafes as the healthcare industry grapples with dozens of inaccessible medications. -
Walgreens won't increase wages for some workers, CEO says
Some employees at Walgreens will not see any "further" wage increases, the chain's CEO said March 28. -
4 drugs are discontinued after US drugmaker closed
Four drugs listed as products with the greatest risk of supply disruption and vulnerability after a U.S. drugmaker closed in February are on back order. The U.S. now has no supply of four others. -
Antibiotic stewardship program shows promising results amid growing resistance: Study
Antibiotics are overprescribed or inappropriately prescribed between 30 and 50 percent of the time, according to a recent study, but the implementation of antibiotic stewardship programs in hospital settings can reduce costs and antimicrobial consumption significantly. -
South Korean company will expand its pharmaceutical footprint in New York
Closures and layoffs from some of the largest drug manufacturers in the U.S. have not rattled South Korean company Lotte Biologics from acquiring a pharmaceutical plant in Syracuse, N.Y., according to a March 27 report from syracuse.com. -
Roche's Genentech lays off 265 as plant closure nears
Genentech, Roche's biotech company based in South San Francisco, is closing a plant and laying off 265 workers, Mercury News reported March 25.
Page 44 of 50